CD8A and neoplasm: Additionally, there appears to be a progenitor subpopulation of CD8+ T-cells both within the tumor and TLDNs that are critical for robust PD-1 therapy responses, suggesting a mechanism of synergy between radiation and immunotherapy, which will be discussed later in this review [8].